Genome of human hepatitis C virus (HCV): Gene organization, sequence diversity, and variation

Microbial and Comparative Genomics

Volumn 5, Issue 3, 2000, Pages 129-151

  Kato, N ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; ENVELOPE PROTEIN; POLYPROTEIN; PROTEIN PRECURSOR; PROTEINASE; VIRUS PROTEIN;

CELL FUNCTION; CHRONIC HEPATITIS; FLAVIVIRUS; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC CODE; GENETIC HETEROGENEITY; GENETIC ORGANIZATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS GENE; VIRUS REPLICATION;

FLAVIVIRIDAE; FLAVIVIRUS; HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS;

EID: 0034484070     PISSN: 10906592     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.1.2000.5.129     Document Type: Review

References (241)

1. Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan
2. Complete coding sequence of hepatitis C virus genotype 6a
3. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
4. Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli
5. Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: Studies of infected donor-recipient clusters
6. Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation
7. The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation
8. Human La antigen is required for the hepatitis C virus internal ribosome entry site (IRES)-mediated translation
9. Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation
10. The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation
11. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions
12. Kinetic and structural analyses of hepatitis C virus polyprotein processing
13. Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase
14. Replication of hepatitis C virus
15. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus
16. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus
17. Secondary structure determination of the conserved 98-base sequence at the 3′terminus of hepatitis C virus genome RNA
18. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease
19. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
20. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs
21. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes
22. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East
23. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa
24. Hepatitis C virus glycoprotein E2 binding to CD81: The role of EIE2 cleavage and protein glycosylation in bioactivity
25. Nucleotide sequence of hepatitis C virus (type 3b) isolated from a Japanese patient with chronic hepatitis C
26. Pretreatment virus load and multiple amino acid substitution in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection
27. Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy
28. The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of genomic and antigenomic RNA
29. Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA
30. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
31. Genetic organization and diversity of the hepatitis C virus
32. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus
33. The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum
34. Translation efficiencies of the 5′ untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel bicistronic reporter assay system
35. Formation of native hepatitis C virus glycoprotein complexes
36. Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma
37. Inhibition of the hepatitis C virus NS3/4A protease. The crystal structure of two protease-inhibitor complexes
38. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: Biological relevance - A review
39. Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro
40. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
41. Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin
42. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
43. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval
44. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor
45. Anatomy of the poliovirus internal ribosome entry site
46. There are two major types of hepatitis C virus in Japan
47. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region
48. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
49. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees
50. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins
51. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A
52. Specific in vitro association between the hepatitis C viral genome and core protein
53. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
54. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
55. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis
56. Predictive factors in eradicating hepatitis C virus using a relatively small dose of interferon
57. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
58. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
59. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase
60. Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites
61. A second hepatitis C virus-encoded proteinase
62. Expression and identification of hepatitis C virus polyprotein cleavage products
63. Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein
64. Expression of processed core protein of hepatitis C virus in mammalian cells
65. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: Relation to viral loads and response to interferon
66. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C
67. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo
68. Hypervariable regions in the putative glycoprotein of hepatitis C virus
69. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis
70. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus
71. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus
72. Diagnosis of hepatitis C
73. Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector
74. Expression and processing of putative nonstructural proteins of hepatitis C virus in insect cells using baculovirus vector
75. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA
76. Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system
77. Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees
78. Detection of different quasispecies of hepatitis C virus core region in cancerous and noncancerous lesions
79. Hepatitis C virus core protein: Carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase
80. Involvement of the 5′ proximal coding sequences of hepatitis C virus with internal initiation of viral translation
81. Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes
82. Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates
83. Ubiquitous presence of cellular proteins that specifically bind to the 3′ terminal region of hepatitis C virus
84. Hepatitis C virus particle detected by immunoelectron microscopic study
85. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients
86. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome
87. Japanese isolates of non-A, non-B hepatitis viral genome show the sequence variations from the original isolate in the U.S.A.
88. Sequence diversity of hepatitis C viral genomes
89. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
90. Molecular structure of the Japanese hepatitis C viral genome
91. Distribution of plural HCV types in Japan
92. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus
93. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses
94. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus
95. Virus isolate-specific antibodies against hypervariable region 1 of the hepatitis C virus second envelope protein, gp70
96. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection
97. Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro
98. Systems to culture hepatitis C virus
99. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity
100. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide
101. In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor
102. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B
103. Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus
104. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees
105. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA
106. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
107. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo
108. Substrate requirements of hepatitis C virus serine proteinase for intermolecular polypeptide cleavage in Escherichia coli
109. Processing of hepatitis C viral polyprotein in Escherichia coli
110. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
111. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection
112. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C
113. Hepatitis C virus core protein: Possible roles in viral pathogenesis
114. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: Elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping
115. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells
116. Hepatitis C virus genomic variability in untreated and immunosuppressed patients
117. Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection
118. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site
119. Identification of hepatitis C virus by immunoelectron microscopy
120. Processing in the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini
121. Hepatitis C virus NS3 serine proteinase: Trans-cleavage requirements and processing kinetics
122. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: Establishment of a cell-free trans-processing assay
123. Regulated processing of hepatitis C virus core protein is linked to subcellular localization
124. Comparative studies of the core gene products of two different hepatitis C virus isolates: Two alternative forms determined by a single amino acid substitution
125. Differential subcellular localization of hepatitis C virus core gene products
126. Interaction between hepatitis C virus core protein and El envelope protein
127. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity
128. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
129. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus
130. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection
131. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site
132. Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus
133. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3
134. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution
135. Homotypic interaction and multimerization of hepatitis C virus core protein
136. Expresison of processed envelope protein of hepatitis C virus in mammalian and insect cells
137. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells
138. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
139. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups
140. Two hepatitis C virus glycoprotein E2 products with different C termini
141. Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2
142. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
143. Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation
144. A new type of hepatitis C virus in patients in Thailand
145. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy
146. Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?
147. Full-length genomic sequence of a hepatitis C virus genotype 2c isolate (BEBE1) and the 2c-specific PCR primers
148. Characterization of the 5′ noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment
149. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier
150. Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein
151. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan
152. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy
153. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus
154. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma
155. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region
156. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions
157. Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-JI) with high homology to USA isolates
158. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability
159. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes
160. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease
161. The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization
162. Binding of hepatitis C virus to CD81
163. A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain
164. Towards a solution for hepatitis C virus hypervariability: Mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants
165. Hyper-variable region 1 sequence stability during hepatitis C virus replication in chimpanzees
166. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties
167. Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine 2321
168. Almost the entire 5′ non-translated region of hepatitis C virus is required for cap-independent translation
169. The influence of AUG codons in the hepatitis C virus 5′ nontranslated region on translation and mapping of the translation initiation window
170. Internal ribosome entry site-mediated translation in hepatitis C virus replication
171. Alpha interferon treatment of chronic hepatitis C
172. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma
173. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
174. Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma
175. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a
176. Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection
177. Full-genome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2
178. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy
179. Biosynthesis and biochemical properties of the hepatitis C virus core protein
180. Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans
181. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A
182. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: Humoral immune response to hypervariable region 1
183. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome
184. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease
185. Hepatitis C virus: Detection of intracellular virus particles by electron microscopy
186. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection
187. A proposed system for the nomenclature of hepatitis C viral genotypes
188. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: Comparison with classifications based upon sequence similarity
189. Characteristics of nucleotide substitution in the hepatitis C virus genome: Constraints on sequence change in coding regions at both ends of the genome
190. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon
191. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
192. Mutation in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa
193. Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells
194. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes
195. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3)
196. Structure and organization of the hepatitis C virus genome isolated from human carriers
197. Cell fusion activity of hepatitis C virus envelope proteins
198. Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers
199. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: Sequence variation within the same individual and among infected individuals
200. A novel sequence found at the 3′ terminus of hepatitis C virus genome
201. Structure of the 3′ terminus of the hepatitis C virus genome
202. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5′ untranslated region of the viral genome
203. Hepatitis C virus NS5B RNA replicase specifically binds ribosomes
204. Alterations to both the primary and predicted secondary structure of atem-loop IIIc of the hepatitis C virus lb 5′ untranslated region (5′ UTR) lead to mutants severely detective in translation which cannot be complemented in trans by the wild-type 5′ UTR sequence
205. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protien: Implication for an escape from antibody
206. Hepatitis C virus polyprotein processing: Kinetics and mutagenic analysis of serine proteinase-dependent cleavage
207. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing
208. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A
209. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
210. Hepatitis C virus epidemiology
211. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups
212. The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups
213. NS3 is a serine protease required for processing of hepatitis C virus polyprotein
214. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection
215. Specific interaction of polypyrimidine tract-binding protein with the extreme 3′-terminal structure of the hepatitis C virus genome, the 3′X
216. Internal ribosome entry site within hepatitis C virus RNA
217. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses
218. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism
219. A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA
220. An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ noncoding region
221. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees
222. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelop and NS1 proteins and the pestivirus envelope glycoproteins
223. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
224. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant
225. Hepatitis C virus: Global prevalence
226. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and low-density lipoprotein receptor
227. A model for the hepatitis C virus envelope glycoprotein E2
228. Full-length sequence of the genome of hepatitis C virus type 3a: Comparative study with different genotypes
229. Genetic organization and diversity of the 3′ noncoding region of the hepatitis C virus genome
230. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region
231. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee
232. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype lb are infectious in vivo
233. In vivo analysis of the 3′ untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone
234. Hepatitis C virus: An infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras
235. The native form and maturation process of hepatitis C virus core protein
236. Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product
237. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis C virus
238. Expression, purification, and partial characterization of HCV RNE polymerase
239. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa
240. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus